Histologic prooffrom 62 sites in 58 patients in whom an ultrasonic abnormality was detected in the absence of palpable or mammographic evidence revealed no malignancy. It is 'suggested that decision to biopsy be made on clinical grounds.
Introduction
Between 1 January 1985 and 30 June 1989, 22421 mammograms were performed at the Cross Cancer Institute, Edmonton, Alberta, Canada. All patients referred to this Institute are examined by mammographically trained radiologists who may take spot compression views of questionable areas ofthe breast, that is of palpable masses, of dense areas or other unusual sites. Biopsy sites, scars and naevi ifpresent, are noted.
Of these, 842 underwent needle localization for suspected breast cancer using mammographic techniques: the Kopan's needle and hooked wire were almost exclusively used. Our positive rate for breast cancer is about 1 in 5 (Castor WH, personal communication).
During this time we were able to identify a subset of 58 patients of asymptomatic women in whom breasts appeared dense on mammography", but no definite palpable mass or radiographic evidence of malignancy was found. These underwent needle localization by ultrasound.
The criteria for biopsy were: a mass, whether well defined or poorly defined, shown on both transverse and longitudinal ultrasound scans, in a patient with a DY breast pattern (Figures 1 and 2 ). All patients Figure 1 . Ultrasound of the breast: 6x4 mm well defined 'lesion' with smooth walls, homogeneous internal echoes mimicking a fibroadenoma)", with lateral 'shadows' and 'tadpole sign >4 Figure 2 . Ultrasound of the breast: 5x4 mm poorly defined lesion with inhomogeneous lateral echoes with a palpable mass or mammographic mass were excluded.
Materials and methods
The lesion was localized using a General Electric RT 3600 Ultrasound machine equipped with a 7.5 Mhz linear array transducer. The needle and wire were introduced into the breast without local anaesthesia after the depth was determined by the distance from the skin to lesion as indicated by the cursors on the screen, and the position on the breast determined by cross-hatching''.
Followingthe procedure, conventional mammograms were obtained (with the wire in situ) as a guide for the surgeon to determine the angulation and depth of the lesion. It has been our experience that the latter factor changes with the position of the breast, that is whether the patient is erect or supine.
Results
There were 58 patients who underwent open biopsy at 62 sites.
The age range was 19-72 years, the median age being 46 years <Table I}. There were two patients with bilateral lesions and two with two lesions in the same breast.
No cases of malignant disease were found ( Table 2 ). The patient with fat necrosis, the patients with cysts and 14 of the patients with fibroadenoma were reported as having associated fibrocystic disease. These were not included in Table 2 . In one patient an initial diagnosis of carcinoma was made but reversed later.
In this Province (1988 Census, 2397400 persons) all biopsy reports of cancer are submitted to the Cancer Registry: a review of the 58 patients' records showed that no cases of cancer had been reported. Table 3 indicates the follow-up time to date.
Thus, histologic proof from 62 sites in 58 patients in whom an ultrasonic abnormality was detected in the absence of palpable or mammographic evidence revealed no malignancy.
Discussion
There has been continued interest in ultrasound mammography ever since Wild and Reid" described it in the differentiation of breast tumours.
At issue here is whether routine biopsy of a solid mass discovered on ultrasound mammography is indicated in the absence of a palpable mass or definite mammographic evidence of abnormality.
The ultrasonic findings of breast carcinomas have been extensively described. Kobayshi" describes infiltrating duct carcinomas as having irregular margins and distal acoustic shadowing in 11 of 14 cases of breast cancer. Cole-Beuglet" in a series of 104 primary breast carcinomas described the ultrasound criteria as either (a) a solid mass with irregular margins, weak, nonuniform and distributed internal echoes, and great acoustic attenuation, or (b) an alteration in the breast architecture manifested as either thickened or retracted Cooper's ligaments or areas of great acoustic attenuation. However, in another paper", she states 'It became apparent that the same lesions that met all benign criteria proved to be malignant at biopsy ... redefine our criteria so that all image masses . . . not purely cystic were considered potentially malignant solid lesions . . . insufficient data are available on tumors that are less than 2 em in diameter determine if ultrasound mammograms should be used as an initial imaging modality for breast examination'. In her study, eight cancers were incorrectly diagnosed as benign with both ultrasound and radiography in patients with biopsy proven cancer, in a series of 1090 patients. Of these only two appear to have shown a benign ultrasonic mass in the absence of Xvray abnormality or clinically palpable mass. We have used the hand held unit in our studies as others, eg Bassett? have found that the automated unit was neither as useful nor as sensitive as the hand held unit.
Maturo" studied 553 symptomatic women with 44 pathologically confirmed breast cancers. Forty were seen echographically, 39 showed clinically perceptible masses, five patients had a non palpable carcinoma which were seen on both xerography and ultrasound. In only one patient, with a dysplastic breast, did the ultrasound show a malignancy not perceivable on the xeromammogram. Maturo states that the poor ability to diagnose consistently microcalcifications is a marked handicap, as 35% of non palpable mammary carcinomas have microcalcifications on the xeromammogram.
Bassett? performed supplementary ultrasound examinations in 1212 of 5378 women referred for mammography. Of these he found benign masses in 29 (4.7%),only one non palpable mammographically undetected carcinoma (0.2%). However there were four carcinomas which were originally mistaken for cysts. He added that ultrasound may play a role in selecting patients with a palpable mass with negative mammographic findings. Egan and Egan'' reported six cancers detected with ultrasound but not with mammography, three of which were not palpable.
Sickles'" in a series of 1000 women referred for routine mammography reported no nonpalpable cancers on ultrasound alone. In his series only 8% of cancers were smaller than 1 em. He points out that ultrasonography cannot detect microcalcifications.
Kopans!' also reported that no nonpalpable cancers were reported with automated ultrasound alone, and says that ultrasound has no place in the early detection of breast malignancy. Fleischer-! states that in daily practice if one diagnosed all shadowing or non shadowing masses of the breast depicted on mammography many missed diagnoses can be made. Lalani'" came to the conclusion that contact B scanning of the breast is more reliable when used with mammography to determine the nature of a clinically palpable mass or mammographic abnormality.
Frazier-", a surgeon, examined 135 consecutive patients for a primary breast complaint either a mass, thickening or pain. These all had DY xeromammogram patterns interpreted as negative for malignancy. In this series, there were five lesions detected by ultrasound that were not seen on xeromammography, three of which were carcinomas.
The decision as to when to biopsy an apparently benign lesion is difficult. It has been shown 15 that the smaller the size of a malignant lesion the more chance oflong-term survival. This has to be weighed against the apparently low incidence of benign appearing carcinomas. We found no cases in our series.
A possible strategy would be to repeat the examination after an interval, but to selectively biopsy immediately all patients with a strong family history, who are over 35 years of age, those who have had a cancer in the opposite breast, those with lobular carcinomas in situ, patients with DY breasts, nulliparous women, those with late parity, and those who have had early menarche, and/or late menopause!",
